1.
SARS-CoV-2 seroprevalence among nursing home residents and staff in Belgium, SCOPE
2.
3.
SARS-CoV-2 seroprevalence among vaccinated nursing home residents and staff in Belgium in August 2021
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
4.
5.
6.
7.